UBS Group
SWAV

UBS Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

UBS Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,138
Closed -$15.3M – 10363
2024
Q1 		$15.3M Sell
47,138
-10,723
-19% -$2.63M ﹤0.01% 1908
2023
Q4 		$11M Buy
57,861
+43,942
+316% +$8.3M ﹤0.01% 2012
2023
Q3 		$2.77M Sell
13,919
-17,860
-56% -$4.22M ﹤0.01% 3131
2023
Q2 		$9.07M Buy
31,779
+2,346
+8% +$651K ﹤0.01% 2031
2023
Q1 		$6.38M Sell
29,433
-15,912
-35% -$3.1M ﹤0.01% 2292
2022
Q4 		$9.32M Buy
45,345
+37,531
+480% +$9.49M ﹤0.01% 1978
2022
Q3 		$2.17M Buy
7,814
+3,420
+78% +$870K ﹤0.01% 3087
2022
Q2 		$840K Buy
4,394
+512
+13% +$90.4K ﹤0.01% 3869
2022
Q1 		$805K Sell
3,882
-3,987
-51% -$657K ﹤0.01% 4316
2021
Q4 		$1.4M Sell
7,869
-18,232
-70% -$3.6M ﹤0.01% 4075
2021
Q3 		$5.37M Sell
26,101
-2,148
-8% -$422K ﹤0.01% 2595
2021
Q2 		$5.36M Buy
28,249
+22,719
+411% +$3.72M ﹤0.01% 2604
2021
Q1 		$721K Buy
5,530
+552
+11% +$66.2K ﹤0.01% 4568
2020
Q4 		$516K Sell
4,978
-1,028
-17% -$89K ﹤0.01% 4580
2020
Q3 		$455K Sell
6,006
-23,509
-80% -$1.33M ﹤0.01% 4272
2020
Q2 		$1.4M Buy
29,515
+748
+3% +$30.8K ﹤0.01% 3210
2020
Q1 		$954K Sell
28,767
-28,972
-50% -$1.15M ﹤0.01% 3394
2019
Q4 		$2.54M Sell
57,739
-76,006
-57% -$2.81M ﹤0.01% 3310
2019
Q3 		$4M Buy
133,745
+120,956
+946% +$5.14M ﹤0.01% 2594
2019
Q2 		$730K Buy
12,789
+12,489
+4,163% +$606K ﹤0.01% 3992
2019
Q1 		$10K Buy
+300
New +$9.97K ﹤0.01% 6832

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group's SWAV Position: Q2 2024 in Review

UBS Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 47,138 shares — an estimated $15.3M sold.

UBS Group first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $15.3M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • UBS Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 47,138 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $15.3M.
  • UBS Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • UBS Group's Shockwave Medical, Inc. Common Stock position peaked at $15.3M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.